McNeil Acquires St. Joseph® Business from Schering-Plough Healthcare Products
McNeil Consumer Healthcare, the marketer of TYLENOL®, today announced that it has acquired the St. Joseph business, best known for its orange-flavored aspirin.
McNeil purchased the 109-year old St. Joseph® brand from Schering-Plough HealthCare Products. The St. Joseph® line currently consists of 81mg adult regimen aspirin. Terms and conditions of the sale were not disclosed.
The acquisition marks the first move into the cardio-protective aspirin market by McNeil, the world leader in over-the-counter analgesics.
McNeil said St. Joseph is an excellent strategic fit with its portfolio, which includes the TYLENOL® and MOTRIN® franchises. The company cited the benefit of low-strength aspirin for consumers who need aspirin for cardiac disease therapy.
McNeil Consumer Healthcare is a member of the Johnson & Johnson Family of Companies and is headquartered in Fort Washington, PA. Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products.
Most read news
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.